Gilead Sciences Shares Trade in the Red for Seventh Consecutive Session (NASDAQ:GILD)
Sciences of GileadNASDAQ: GOLDEN) shares are trading in the red for the seventh day in a row, falling 0.18% to ...
Sciences of GileadNASDAQ: GOLDEN) shares are trading in the red for the seventh day in a row, falling 0.18% to ...
in focus Heading into the biopharmaceutical sector's third-quarter earnings season, Bank of America has taken a bullish stance on Eli ...
Justin Sullivan/Getty Images News Gilead (NASDAQ:GILD) announced Sunday that its antibody-drug conjugate Trodelvy and Merck’s (NYSE:MRK) anti-PD-1 immunotherapy Keytruda cut ...